*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. In a judgment of 30 January 2020 handed down on a reference for a preliminary ruling by the Competition Appeal Tribunal of the United Kingdom, the Court of Justice of the European [Union Court of Justice] provides interesting clarifications with regard to both the concept of anti-competitive agreement by object or effect and the concept of abuse of a dominant position linked to agreements signed between competitors (see above. Chron ententes). Only the notion of abuse of a dominant position will be the subject of a detailed commentary in this column. The case originated with the laboratory GlaxoSmithKline[ GSK], which markets, in particular in the United
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.